Lipoxin A4 and lipoxin A4 receptor expression in induced sputum of asthmatic children Source: Eur Respir J 2007; 30: Suppl. 51, 267s Year: 2007
Increased leukotriene and lower prostaglandin E2 concentrations in induced sputum of patients with eosinophilic asthma Source: Eur Respir J 2005; 26: Suppl. 49, 733s Year: 2005
Leukotriene B4 levels in sputum from asthma patients Source: ERJ Open Res, 2 (4) 00088-2015; 10.1183/23120541.00088-2015 Year: 2016
Quantitative assessment of cysteinyl leukotrienes in human sputum during the allergen-induced asthmatic response and the effect of GSK2190915, a 5-lipoxygenase activating protein (FLAP) inhibitor Source: Annual Congress 2011 - Diagnosis and treatment of inflammatory respiratory diseases Year: 2011
Lipoxin and eotaxin as markers of severity in patients with bronchial asthma Source: Annual Congress 2008 - Risk factors for allergic asthma and allergic rhinitis Year: 2008
Do leukotriene antagonists reduce eosinophil numbers in induced sputum from asthmatic patients as a consequence of increased apoptosis induction? Source: Eur Respir J 2002; 20: Suppl. 38, 584s Year: 2002
Prostaglandin E2 and cysteinyl leukotriene concentrations in sputum supernatant in smoking asthma Source: Annual Congress 2011 - Bronchial hyperresponsiveness and exhaled and sputum biomarkers Year: 2011
Eosinophil activation and cysteinyl leukotriene production in infants with RSV positive bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001
Downregulation of prostaglandin E2 in bronchial fibroblasts of asthmatic patients Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Elevated IL-10 level but not cysteinyl leukotrienes (CysLT) release from leukocytes in vitro correlates with good response to treatment with montelukast in asthmatic patients Source: International Congress 2014 – Asthma and COPD management Year: 2014
Interaction between eotaxin and IL-13 in serum and sputum: comparison between normal and allergic asthmatic children Source: Eur Respir J 2004; 24: Suppl. 48, 396s Year: 2004
Role of leptin and cysteinyl leukotrienes in the pathogenesis of exercise-induced bronchoconstriction in obese asthmatic children Source: International Congress 2018 – New perspectives on asthma, cough and laryngeal obstruction Year: 2018
Cysteinyl leukotrienes and leukotriene B4 in expired breath condensate in patients with chronic asthma treated with montelukast Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003
Higher expression of lipoxygenase and cyclooxygenase pathways in bronchial than alveolar lavage from allergic asthmatics Source: Virtual Congress 2021 – Clinical features and new biomarkers of asthma, COPD and chronic cough Year: 2021
Urinary cysteinyl leukotriene levels in acute asthma Source: Eur Respir J 2003; 22: Suppl. 45, 179s Year: 2003
Prostaglandin E2 levels are elevated in nasal lavages from asthmatic patients with allergic rhinitis Source: Eur Respir J 2003; 22: Suppl. 45, 109s Year: 2003
Reduced 15-lipoxygenase 2 and lipoxin A4/leukotriene B4 ratio in children with cystic fibrosis Source: Eur Respir J 2014; 44: 394-404 Year: 2014
Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Safety of sputum induction in asthmatic children Source: Eur Respir J 2003; 22: Suppl. 45, 399s Year: 2003
Imbalance of anti-inflammatory (lipoxin A4) and pro-inflammatory (leukotrien B4) arachidonic acid products in exhaled breath condensate of severe refractory asthma. Source: International Congress 2014 – Airway biomarkers Year: 2014